Oncology

1. In patients with hepatocellular carcinoma, male sex was associated with significantly higher mortality compared to female sex, but the...

1. In this randomized controlled trial involving patients with disease progression during first-line treatment for breast cancer, giredestrant plus everolimus...

1. In this comparative study, patients with advanced epithelial ovarian cancer who received neoadjuvant chemotherapy were found to have reduced...

1. Adjuvant chemotherapy was not associated with improved relapse-free or overall survival in patients with localized appendiceal adenocarcinoma. 2. Patients...

1. Tak and colleagues developed a temporal deep-learning model to predict one-year pediatric glioma recurrence using surveillance magnetic resonance imaging...

1. Daraxonrasib is the first-in-class RAS inhibitor approved for metastatic pancreatic adenocarcinoma, addressing a molecular pathway that drives most pancreatic...

1. In this prospective cohort study, mortality risk was higher among participants with hemoglobin concentrations below, 0 to 1 g/dL...

1. In this retrospective cohort study, historically redlined grade C and D Census tracts had lower breast cancer screening rates...

1. The use of molecularly guided therapy (MGT) was associated with significantly improved progression-free survival (PFS) compared with standard platinum-based...

1. In patients with previously treated advanced RAS-mutant non–small-cell lung cancer, daraxonrasib produced objective responses in approximately one-third of subjects...